Illuminas hires Coffin to lead new healthcare practice
Coffin (pictured) previously headed the pharmaceuticals division at Holden Pearmain and over the course of his career has served as healthcare director at Hall & Partners, senior executive at Isis Research, marketing executive at Lifescan and senior analyst at Roche Pharmaceuticals.
The new healthcare team will work with clients to ensure that research is acted upon and helps drive better business decisions.
Illuminas CEO John Connaughton said: “Dan fits perfectly with the Illuminas philosophy of offering bespoke, method-neutral solutions to solve complex business problems.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments